Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
7.14
+0.14 (2.00%)
Jun 27, 2025, 4:00 PM - Market closed
Journey Medical Revenue
Journey Medical had revenue of $13.14M in the quarter ending March 31, 2025, with 0.84% growth. This brings the company's revenue in the last twelve months to $56.24M, down -29.69% year-over-year. In the year 2024, Journey Medical had annual revenue of $56.13M, down -29.11%.
Revenue (ttm)
$56.24M
Revenue Growth
-29.69%
P/S Ratio
2.39
Revenue / Employee
$1,371,780
Employees
41
Market Cap
166.33M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
DERM News
- 4 days ago - Journey Medical to Join Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 8 days ago - Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference - GlobeNewsWire
- 19 days ago - Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - GlobeNewsWire
- 6 weeks ago - Journey Medical Corporation (DERM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 7 weeks ago - Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
- 3 months ago - Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer - GlobeNewsWire